Related Experiment Videos
Impact of cachexia on outcomes in aggressive lymphomas
Reem Karmali1, Taha Alrifai2, Ibtihaj A M Fughhi2
1Division of Hematology, Oncology and Cell Therapy, Rush University Medical Center, Chicago, IL, USA. reem.karmali@northwestern.edu.
Annals of Hematology
|April 19, 2017
Summary
Cancer cachexia, a state of involuntary weight loss, significantly worsens survival in aggressive lymphomas. The cachexia index (CXI) can identify patients with poor prognoses, suggesting targeted therapies may improve outcomes.
Area of Science:
- Oncology
- Metabolism
- Clinical Research
Background:
- Cancer cachexia involves involuntary weight loss and altered body composition.
- Effective clinical parameters are needed to measure cancer cachexia and its impact.
- Identifying cachexia's association with outcomes may lead to new therapeutic targets.
Purpose of the Study:
- To assess the association between cancer cachexia and patient outcomes in aggressive lymphomas.
- To evaluate the prognostic value of the cachexia index (CXI) in this patient population.
Main Methods:
- Retrospective analysis of 86 non-Hodgkin lymphoma (NHL) patients.
- Utilized the cachexia index (CXI) to categorize patients as 'cachectic' or 'non-cachectic'.
- Assessed progression-free survival (PFS) and overall survival (OS) using log-rank test and Cox regression.
Main Results:
- Cachectic patients (CXI <49.8) showed significantly worse PFS (HR 2.18, p=0.044).
- Cachectic patients also had significantly worse OS (HR 4.05, p=0.004).
- The CXI demonstrated prognostic value in aggressive lymphomas.
Conclusions:
- Cancer cachexia, as measured by the CXI, is a significant negative prognostic factor in aggressive lymphomas.
- Novel therapeutic strategies targeting cachexia reversal may improve survival for these patients.